50 related articles for article (PubMed ID: 8645263)
1. Transcriptional repression activity of N-MYC protein requires phosphorylation by MAP kinase.
Manabe A; Iguchi-Ariga SM; Iizuka H; Ariga H
Biochem Biophys Res Commun; 1996 Feb; 219(3):813-23. PubMed ID: 8645263
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation sites mapping in the N-terminal domain of c-myc modulate its transforming potential.
Henriksson M; Bakardjiev A; Klein G; Lüscher B
Oncogene; 1993 Dec; 8(12):3199-209. PubMed ID: 8247524
[TBL] [Abstract][Full Text] [Related]
3. Extracellular-regulated kinase 1/2, Jun N-terminal kinase, and c-Jun are involved in NF-kappa B-dependent IL-6 expression in human monocytes.
Tuyt LM; Dokter WH; Birkenkamp K; Koopmans SB; Lummen C; Kruijer W; Vellenga E
J Immunol; 1999 Apr; 162(8):4893-902. PubMed ID: 10202034
[TBL] [Abstract][Full Text] [Related]
4. Evidence for an important role of serine 16 and its phosphorylation in the stabilization of c-Mos.
Pham CD; Vuyyuru VB; Yang Y; Bai W; Singh B
Oncogene; 1999 Jul; 18(30):4287-94. PubMed ID: 10439036
[TBL] [Abstract][Full Text] [Related]
5. Site-specific modulation of c-Myc cotransformation by residues phosphorylated in vivo.
Pulverer BJ; Fisher C; Vousden K; Littlewood T; Evan G; Woodgett JR
Oncogene; 1994 Jan; 9(1):59-70. PubMed ID: 8302604
[TBL] [Abstract][Full Text] [Related]
6. Activation of protein kinase C increases phosphorylation of the L-myc trans-activator domain at a GSK-3 target site.
Saksela K; Mäkelä TP; Hughes K; Woodgett JR; Alitalo K
Oncogene; 1992 Feb; 7(2):347-53. PubMed ID: 1312697
[TBL] [Abstract][Full Text] [Related]
7. In vivo regulation of single copy and amplified N-myc in human neuroblastoma cells.
Lutz W; Schwab M
Oncogene; 1997 Jul; 15(3):303-15. PubMed ID: 9233765
[TBL] [Abstract][Full Text] [Related]
8. Regions controlling hyperphosphorylation and conformation of the retinoblastoma gene product are independent of domains required for transcriptional repression.
Hamel PA; Gill RM; Phillips RA; Gallie BL
Oncogene; 1992 Apr; 7(4):693-701. PubMed ID: 1565466
[TBL] [Abstract][Full Text] [Related]
9. The amino terminus of the retinoblastoma (Rb) protein associates with a cyclin-dependent kinase-like kinase via Rb amino acids required for growth suppression.
Sterner JM; Tao Y; Kennett SB; Kim HG; Horowitz JM
Cell Growth Differ; 1996 Jan; 7(1):53-64. PubMed ID: 8788033
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation regulates Myc expression via prolonged activation of the mitogen-activated protein kinase pathway.
Wang Z; Ge L; Wang M; Carr BI
J Cell Physiol; 2006 Jul; 208(1):133-40. PubMed ID: 16596619
[TBL] [Abstract][Full Text] [Related]
11. Mad4 is regulated by a transcriptional repressor complex that contains Miz-1 and c-Myc.
Kime L; Wright SC
Biochem J; 2003 Feb; 370(Pt 1):291-8. PubMed ID: 12418961
[TBL] [Abstract][Full Text] [Related]
12. Identification of protein kinase C phosphorylation sites in the angiotensin II (AT1A) receptor.
Qian H; Pipolo L; Thomas WG
Biochem J; 1999 Nov; 343 Pt 3(Pt 3):637-44. PubMed ID: 10527943
[TBL] [Abstract][Full Text] [Related]
13. The activity of the Ets transcription factor PEA3 is regulated by two distinct MAPK cascades.
O'Hagan RC; Tozer RG; Symons M; McCormick F; Hassell JA
Oncogene; 1996 Sep; 13(6):1323-33. PubMed ID: 8808707
[TBL] [Abstract][Full Text] [Related]
14. Mouse Sin3A interacts with and can functionally substitute for the amino-terminal repression of the Myc antagonist Mxi1.
Rao G; Alland L; Guida P; Schreiber-Agus N; Chen K; Chin L; Rochelle JM; Seldin MF; Skoultchi AI; DePinho RA
Oncogene; 1996 Mar; 12(5):1165-72. PubMed ID: 8649810
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase C modulation of insulin receptor substrate-1 tyrosine phosphorylation requires serine 612.
De Fea K; Roth RA
Biochemistry; 1997 Oct; 36(42):12939-47. PubMed ID: 9335553
[TBL] [Abstract][Full Text] [Related]
16. Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc.
Gupta K; Anand G; Yin X; Grove L; Prochownik EV
Oncogene; 1998 Mar; 16(9):1149-59. PubMed ID: 9528857
[TBL] [Abstract][Full Text] [Related]
17. Transactivation of gene expression by Myc is inhibited by mutation at the phosphorylation sites Thr-58 and Ser-62.
Gupta S; Seth A; Davis RJ
Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3216-20. PubMed ID: 8386367
[TBL] [Abstract][Full Text] [Related]
18. Functional analysis of Burkitt's lymphoma mutant c-Myc proteins.
Smith-Sørensen B; Hijmans EM; Beijersbergen RL; Bernards R
J Biol Chem; 1996 Mar; 271(10):5513-8. PubMed ID: 8621409
[TBL] [Abstract][Full Text] [Related]
19. c-Myc transactivation domain-associated kinases: questionable role for map kinases in c-Myc phosphorylation.
Lutterbach B; Hann SR
J Cell Biochem; 1999 Mar; 72(4):483-91. PubMed ID: 10022608
[TBL] [Abstract][Full Text] [Related]
20. Site-directed mutagenesis of tyrosine hydroxylase. Role of serine 40 in catalysis.
Wu J; Filer D; Friedhoff AJ; Goldstein M
J Biol Chem; 1992 Dec; 267(36):25754-8. PubMed ID: 1361189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
